drugset / Trial / NCT06176222
Combined Use of Naldebain® ER Injection and Precedex® After VATS
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The goal of this clinical trial is to investigate the effects of combined use of Naldebain® ER Injection and Precedex® in patients received video-assisted thoracoscopic surgery. The main questions it aims to answer are: * the pain intensity after surgery * the level of dizziness after surgery Participants will receice ultrasound-guided thoracic paravertebral nerve block, intramuscular Naldebain® ER injection and intravenous Precedex® infusion. If there is a comparison group: Researchers will compare experimental group with placebo group to see if pain and dizziness after surgery can reduced.
Timeline
- Start
- 2023-12-28
- Primary completion
- 2025-12-31
- Completion
- 2026-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.1 ug/kg | Intravenous |
| Subject | Dexmedetomidine | Other / unclassified | 0.4 ug/kg | Intravenous |